GLECKEL LOUIS MD purchased 22.3% of their position (50K shares) of PROPHASE LABS, INC. on the open market
Open‑market purchase worth $137.5K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/17/2020ACC: 0001493152-20-016097
+50K
Net shares
Net buyer
$137.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
50K acquired
Non-Derivative Transactions1
Common Stock, par value $0.0005
Direct
Shares
+50K
Price / share
$2.75
Trade value
$137.50K
% of position
22.3%
8/13/2020
223.84K→273.84K
Total
Net shares
+50K
Net value
$137.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0005 Direct | 8/13/2020 | P · Purchase | +50K | $2.75 | $137.50K | 22.3% | 223.84K | 273.84K |
| Total | +50K | $137.50K | ||||||
Derivative Transactions0
No derivative transactions reported